Dimethylformamide → Glycine, N-(2,1,3-benzoxadiazol-5-ylcarbonyl)-, methyl ester
Reaction equation
[N:1]1[O:5][N:4]=[C:3]2[CH:6]=[C:7]([C:10]([OH:12])=O)[CH:8]=[CH:9][C:2]=12.C1C=CC2N([OH:22])N=NC=2C=1.[CH3:23][CH2:24][N:25]=C=NCCCN(C)C.Cl.CCN(C(C)C)C(C)C.CN([CH:47]=[O:48])C>[Cl-].[Na+].O>[CH3:47][O:48][C:23](=[O:22])[CH2:24][NH:25][C:10]([C:7]1[CH:8]=[CH:9][C:2]2[C:3]([CH:6]=1)=[N:4][O:5][N:1]=2)=[O:12]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
492 mg (3 mmol) benzo[1,2,5]oxadiazole-5-carboxylic acid 376 mg (1 eq.) glycine methyl ester hydrochloride, 486 mg (1.2 eq.) HOBt and 690 mg (1.2 eq.) EDC.HCl are dissolved in 20 mL DMF under argon and the reaction mixture is stirred at room temperature for 90 minutes after addition of 2 mL (4 eq.) Hünig's base. The reaction mixture is poured onto ice and brine, and extracted with ethyl acetate. The combined organic phases are dried with sodium sulfate and evaporated to yield the desired product as a beige powder. MS (ES+): 236 (M+1).
Workup
- extractionextracted with ethyl acetate
- dry with materialThe combined organic phases are dried with sodium sulfate
- customevaporated
Sources & evidence
- ORD record
- ord-73831c29fabb4e889fa55e328dcbdffe
- Source dataset
- uspto-grants-2009_12
- Patent number
- US07632851B2
Reaction notes
Loading…